These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Clinical experience with an indomethacin-phenylbutazone combination in various rheumatic diseases]. Hernández Peńa M Rev Esp Reum Enferm Osteoartic; 1973; 16(2):111-31. PubMed ID: 4541698 [No Abstract] [Full Text] [Related]
6. [Initial results of therapy with Sigma-Elmedal]. Gniwotta E; Schäfer HJ Z Allgemeinmed; 1972 Feb; 48(5):238-9. PubMed ID: 4553931 [No Abstract] [Full Text] [Related]
7. [The association of paracetamol and phenylbutazone in rheumatology. Preliminary report]. Wettreich W Hospital (Rio J); 1966 Aug; 70(2):427-32. PubMed ID: 5300316 [No Abstract] [Full Text] [Related]
8. The use of steroids in the treatment of rheumatic diseases. Scott JT Practitioner; 1972 Jan; 208(243):18-27. PubMed ID: 4335557 [No Abstract] [Full Text] [Related]
9. [Sodium diclofenac in the ambulatory therapy of joint inflammation and pain. Multicentric open-ended research performed by 223 Italian physicians]. Baroni L; Comoglio T; Trombetta N; Cornelli U Clin Ter; 1982 Feb; 100(4):383-99. PubMed ID: 7044660 [No Abstract] [Full Text] [Related]
10. [Considerations on the use of aminophenazone and aminopropylon in equimolecular association in rheumatology]. Colamussi V; Bazzanini G Minerva Med; 1968 Jan; 59(3):71-8. PubMed ID: 5300479 [No Abstract] [Full Text] [Related]
11. [Combination of low phenylbutazone and dexamethasone dosage with a large administration of vitamin B12 for therapy of rheumatic diseases]. Krueger GA Med Welt; 1969 Apr; 17():1030-4. PubMed ID: 5305801 [No Abstract] [Full Text] [Related]
12. [Improved compatibility of phenylbutazone drugs. A new antirheumatic agent in sugar-coated tablets, suppositories, ampoules]. Dürrigl T; Vitaus M Munch Med Wochenschr; 1969 Mar; 111(10):564-8. PubMed ID: 4239143 [No Abstract] [Full Text] [Related]
13. [Our 1st experiences with indocid in the therapy of rheumatic diseases]. Car A Reumatizam; 1968; 15(1):1-6. PubMed ID: 5301771 [No Abstract] [Full Text] [Related]
14. [A system of antirheumatic preparations for differentiated therapy]. Pflitsch D Z Allgemeinmed; 1971 Sep; 47(27):1406-8. PubMed ID: 5315766 [No Abstract] [Full Text] [Related]
15. [Clinical study of the effects of the topical use of DF-307]. Rivadeneyra F Medicina (Mex); 1965 Oct; 45(974):514-7. PubMed ID: 5295350 [No Abstract] [Full Text] [Related]
16. [What can we expect from an anti-inflammatory agent after 3 years of experimentation and rheumatologic practice?]. Weissenbach R Therapeutique; 1972 Dec; 48(10):685-8. PubMed ID: 4540974 [No Abstract] [Full Text] [Related]
17. [Studies of gastric tolerance of coated alka-butazolidin tablets]. Richter H; Atefie K; Gangl A; Thumb N Wien Z Inn Med; 1970; 51(9):430-6. PubMed ID: 5316365 [No Abstract] [Full Text] [Related]
18. [Clinical experience with a new antiphlogistic analgesic]. Auer B Med Welt; 1970 Apr; 17():787-9. PubMed ID: 4245857 [No Abstract] [Full Text] [Related]
19. [Fast and reliable relief from pain during treatment of rheumatic diseases]. Krueger GA Med Welt; 1970 Jan; 4():149-53. PubMed ID: 5311024 [No Abstract] [Full Text] [Related]
20. [Meprotixol--a new antirheumatic drug]. Kogstad O; Rossel I Nord Med; 1970; 83(23):725-7. PubMed ID: 4913199 [No Abstract] [Full Text] [Related] [Next] [New Search]